ID

23422

Descripción

Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D); ODM derived from: https://clinicaltrials.gov/show/NCT00392678

Link

https://clinicaltrials.gov/show/NCT00392678

Palabras clave

Versiones (1)
  1. 4/7/17 4/7/17 -
Subido en

4 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes NCT00392678

Inglés

Eligibility Type 2 Diabetes NCT00392678

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. type 2 diabetes on diet and exercise therapy or monotherapy with metformin, insulin secretagogue, or alpha-glucosidase inhibitors, or a low-dose combination of these at
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise regime | Metformin | Insulin | alpha-Glucosidase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0454291
UMLS CUI [4]
C0025598
UMLS CUI [5]
C0021641
UMLS CUI [6]
C1299007
≤ 50% maximal dose (see appendix). dosing is stable for 8 weeks prior to randomization.
Descripción

Combined Modality Therapy Low dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C0445550
UMLS CUI [1,3]
C0205360
2. fpg ≤ 225 mg/dl and hba1c>7% and ≤9.5% at screening
Descripción

Plasma fasting glucose measurement | Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2]
C0019018
3. age ≥18 and <75
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
4. women of childbearing potential agree to use an appropriate contraceptive method (hormonal, iud, or diaphragm)
Descripción

Childbearing Potential Contraceptive methods | Hormonal contraception | Intrauterine Devices | Vaginal contraceptive diaphragm

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C2985296
UMLS CUI [3]
C0021900
UMLS CUI [4]
C0042241
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. type 1 diabetes and/or history of ketoacidosis determined by medical history
Descripción

Diabetes Mellitus, Insulin-Dependent | Ketoacidosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0220982
2. history of severe diabetic neuropathy including autonomic neuropathy, gastroparesis or lower limb ulceration or amputation
Descripción

Diabetic Neuropathy Severe | Autonomic neuropathy | Gastroparesis | Leg Ulcer | Amputation of lower limb

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011882
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0259749
UMLS CUI [3]
C0152020
UMLS CUI [4]
C0023223
UMLS CUI [5]
C0337308
3. history of long-term therapy with insulin (>30 days) within the last year
Descripción

Insulin Long-term

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0443252
4. therapy with rosiglitazone (avandia) or pioglitazone (actos), or extendin-4 (byetta), alone or in combination in the previous 6 months
Descripción

rosiglitazone | Avandia | pioglitazone | Actos | exenatide | Byetta | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0289313
UMLS CUI [2]
C0875967
UMLS CUI [3]
C0071097
UMLS CUI [4]
C0875954
UMLS CUI [5]
C0167117
UMLS CUI [6]
C1636686
UMLS CUI [7]
C0009429
5. pregnancy or lactation
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
6. patients requiring corticosteroids within 3 months or recurrent continuous oral corticosteroid treatment (more than 2 weeks)
Descripción

Adrenal Cortex Hormones | Adrenal Cortex Hormones Oral Recurrent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C2945760
7. use of weight loss drugs [e.g., xenical (orlistat), meridia (sibutramine), acutrim (phenylpropanol-amine), or similar over-the-counter medications] within 3 months of screening or intentional weight loss of ≥ 10 lbs in the previous 6 months
Descripción

Weight-Loss Agents | Xenical | orlistat | Meridia | sibutramine | Phenylpropanolamine | Non-Prescription Drugs Similar | Intentional weight loss

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0376606
UMLS CUI [2]
C0732649
UMLS CUI [3]
C0076275
UMLS CUI [4]
C0635898
UMLS CUI [5]
C0074493
UMLS CUI [6]
C0031495
UMLS CUI [7,1]
C0013231
UMLS CUI [7,2]
C2348205
UMLS CUI [8]
C1563041
8. surgery within 30 days prior to screening
Descripción

Operative Surgical Procedures

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
9. serum creatinine >1.4 for women and >1.5 for men or egfr <60 [possible chronic kidney disease stage 3 or greater calculated using the modification of diet in renal disease (mdrd) equation.
Descripción

Creatinine measurement, serum | Gender | Estimated Glomerular Filtration Rate | Chronic Kidney Disease Stage MDRD

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
UMLS CUI [3]
C3811844
UMLS CUI [4,1]
C1561643
UMLS CUI [4,2]
C1306673
UMLS CUI [4,3]
C3839656
10. history of chronic liver disease including hepatitis b or c
Descripción

Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2]
C0524909
UMLS CUI [3]
C0524910
11. history of peptic ulcer or endoscopy demonstrated gastritis
Descripción

Peptic Ulcer | Gastritis Endoscopy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030920
UMLS CUI [2,1]
C0017152
UMLS CUI [2,2]
C0014245
12. history of acquired immune deficiency syndrome or human immunodeficiency virus (hiv)
Descripción

Acquired Immunodeficiency Syndrome | HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001175
UMLS CUI [2]
C0019693
13. history of malignancy, except participants who have been disease-free for greater than 10 years, or whose only malignancy has been basal or squamous cell skin carcinoma
Descripción

Malignant Neoplasms | Disease Free of | Basal cell carcinoma | Squamous cell carcinoma of skin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0332296
UMLS CUI [3]
C0007117
UMLS CUI [4]
C0553723
14. new york heart association class iii or iv cardiac status or hospitalization for congestive heart failure
Descripción

Cardiac Status New York Heart Association Classification | Hospitalization Congestive heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1999091
UMLS CUI [1,2]
C1275491
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0018802
15. history of unstable angina, myocardial infarction, cerebrovascular accident, transient ischemic attack or any revascularization within 6 months
Descripción

Angina, Unstable | Myocardial Infarction | Cerebrovascular accident | Transient Ischemic Attack | Revascularization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0038454
UMLS CUI [4]
C0007787
UMLS CUI [5]
C0581603
16. uncontrolled hypertension (defined as systolic blood pressure >150 mmhg or diastolic blood pressure >95 mmhg on three or more assessments on more than one day)
Descripción

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
17. history of drug or alcohol abuse, or current weekly alcohol consumption >10 units/week (1 unit = 1 beer, 1 glass of wine, 1 mixed cocktail containing 1 ounce of alcohol)
Descripción

Substance Use Disorders | Alcohol consumption U/week | Beer U/week | Wine U/week | Cocktail Containing Alcohol U/week

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2,1]
C0001948
UMLS CUI [2,2]
C0560588
UMLS CUI [3,1]
C0004922
UMLS CUI [3,2]
C0560588
UMLS CUI [4,1]
C0043188
UMLS CUI [4,2]
C0560588
UMLS CUI [5,1]
C0678420
UMLS CUI [5,2]
C0332256
UMLS CUI [5,3]
C0001962
UMLS CUI [5,4]
C0560588
18. hemoglobin <12 g/dl (males), <10 g/dl (females) at screening
Descripción

Hemoglobin measurement | Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0079399
19. platelets <100,000 cu mm at screening.
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
20. ast (sgot) >2.50 x uln or alt (sgpt) >2.50 x uln at screening
Descripción

Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
21. total bilirubin >1.50 x uln at screening
Descripción

Elevated total bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0741494
22. triglycerides (tg) >500 mg/dl at screening
Descripción

Triglycerides measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202236
23. poor mental function or any other reason to expect patient difficulty in complying with the requirements of the study
Descripción

Mental function Poor | Reason for Protocol Compliance Limited

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0563143
UMLS CUI [1,2]
C0542537
UMLS CUI [2,1]
C0392360
UMLS CUI [2,2]
C0525058
UMLS CUI [2,3]
C0439801
24. previous allergy to aspirin
Descripción

Aspirin allergy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004058
25. chronic or continuous use (daily for more than 7 days) of nonsteroidal anti-inflammatory drugs within the preceding 2 months
Descripción

Non-Steroidal Anti-Inflammatory Agents chronic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C0205191
26. use of warfarin (coumadin), clopidogrel (plavix) or other anticoagulants
Descripción

Warfarin | Coumadin | clopidogrel | Plavix | Anticoagulants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0043031
UMLS CUI [2]
C0699129
UMLS CUI [3]
C0070166
UMLS CUI [4]
C0633084
UMLS CUI [5]
C0003280
27. use of probenecid (benemid, probalan), sulfinpyrazone (anturane) or other uricosuric agents
Descripción

Probenecid | Benemid | Sulfinpyrazone | Anturane | Uricosuric Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0033209
UMLS CUI [2]
C0591159
UMLS CUI [3]
C0038742
UMLS CUI [4]
C0591099
UMLS CUI [5]
C0041983
Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes NCT00392678

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Diet therapy | Exercise regime | Metformin | Insulin | alpha-Glucosidase Inhibitors
Item
1. type 2 diabetes on diet and exercise therapy or monotherapy with metformin, insulin secretagogue, or alpha-glucosidase inhibitors, or a low-dose combination of these at
boolean
C0011860 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0454291 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0021641 (UMLS CUI [5])
C1299007 (UMLS CUI [6])
Combined Modality Therapy Low dose Stable
Item
≤ 50% maximal dose (see appendix). dosing is stable for 8 weeks prior to randomization.
boolean
C0009429 (UMLS CUI [1,1])
C0445550 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Plasma fasting glucose measurement | Glycosylated hemoglobin A
Item
2. fpg ≤ 225 mg/dl and hba1c>7% and ≤9.5% at screening
boolean
C0583513 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Age
Item
3. age ≥18 and <75
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Hormonal contraception | Intrauterine Devices | Vaginal contraceptive diaphragm
Item
4. women of childbearing potential agree to use an appropriate contraceptive method (hormonal, iud, or diaphragm)
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C2985296 (UMLS CUI [2])
C0021900 (UMLS CUI [3])
C0042241 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Ketoacidosis
Item
1. type 1 diabetes and/or history of ketoacidosis determined by medical history
boolean
C0011854 (UMLS CUI [1])
C0220982 (UMLS CUI [2])
Diabetic Neuropathy Severe | Autonomic neuropathy | Gastroparesis | Leg Ulcer | Amputation of lower limb
Item
2. history of severe diabetic neuropathy including autonomic neuropathy, gastroparesis or lower limb ulceration or amputation
boolean
C0011882 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0259749 (UMLS CUI [2])
C0152020 (UMLS CUI [3])
C0023223 (UMLS CUI [4])
C0337308 (UMLS CUI [5])
Insulin Long-term
Item
3. history of long-term therapy with insulin (>30 days) within the last year
boolean
C0021641 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
rosiglitazone | Avandia | pioglitazone | Actos | exenatide | Byetta | Combined Modality Therapy
Item
4. therapy with rosiglitazone (avandia) or pioglitazone (actos), or extendin-4 (byetta), alone or in combination in the previous 6 months
boolean
C0289313 (UMLS CUI [1])
C0875967 (UMLS CUI [2])
C0071097 (UMLS CUI [3])
C0875954 (UMLS CUI [4])
C0167117 (UMLS CUI [5])
C1636686 (UMLS CUI [6])
C0009429 (UMLS CUI [7])
Pregnancy | Breast Feeding
Item
5. pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Adrenal Cortex Hormones | Adrenal Cortex Hormones Oral Recurrent
Item
6. patients requiring corticosteroids within 3 months or recurrent continuous oral corticosteroid treatment (more than 2 weeks)
boolean
C0001617 (UMLS CUI [1])
C0001617 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C2945760 (UMLS CUI [2,3])
Weight-Loss Agents | Xenical | orlistat | Meridia | sibutramine | Phenylpropanolamine | Non-Prescription Drugs Similar | Intentional weight loss
Item
7. use of weight loss drugs [e.g., xenical (orlistat), meridia (sibutramine), acutrim (phenylpropanol-amine), or similar over-the-counter medications] within 3 months of screening or intentional weight loss of ≥ 10 lbs in the previous 6 months
boolean
C0376606 (UMLS CUI [1])
C0732649 (UMLS CUI [2])
C0076275 (UMLS CUI [3])
C0635898 (UMLS CUI [4])
C0074493 (UMLS CUI [5])
C0031495 (UMLS CUI [6])
C0013231 (UMLS CUI [7,1])
C2348205 (UMLS CUI [7,2])
C1563041 (UMLS CUI [8])
Operative Surgical Procedures
Item
8. surgery within 30 days prior to screening
boolean
C0543467 (UMLS CUI [1])
Creatinine measurement, serum | Gender | Estimated Glomerular Filtration Rate | Chronic Kidney Disease Stage MDRD
Item
9. serum creatinine >1.4 for women and >1.5 for men or egfr <60 [possible chronic kidney disease stage 3 or greater calculated using the modification of diet in renal disease (mdrd) equation.
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C3811844 (UMLS CUI [3])
C1561643 (UMLS CUI [4,1])
C1306673 (UMLS CUI [4,2])
C3839656 (UMLS CUI [4,3])
Chronic liver disease | Hepatitis B, Chronic | Hepatitis C, Chronic
Item
10. history of chronic liver disease including hepatitis b or c
boolean
C0341439 (UMLS CUI [1])
C0524909 (UMLS CUI [2])
C0524910 (UMLS CUI [3])
Peptic Ulcer | Gastritis Endoscopy
Item
11. history of peptic ulcer or endoscopy demonstrated gastritis
boolean
C0030920 (UMLS CUI [1])
C0017152 (UMLS CUI [2,1])
C0014245 (UMLS CUI [2,2])
Acquired Immunodeficiency Syndrome | HIV Infection
Item
12. history of acquired immune deficiency syndrome or human immunodeficiency virus (hiv)
boolean
C0001175 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
Malignant Neoplasms | Disease Free of | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
13. history of malignancy, except participants who have been disease-free for greater than 10 years, or whose only malignancy has been basal or squamous cell skin carcinoma
boolean
C0006826 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4])
Cardiac Status New York Heart Association Classification | Hospitalization Congestive heart failure
Item
14. new york heart association class iii or iv cardiac status or hospitalization for congestive heart failure
boolean
C1999091 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
Angina, Unstable | Myocardial Infarction | Cerebrovascular accident | Transient Ischemic Attack | Revascularization
Item
15. history of unstable angina, myocardial infarction, cerebrovascular accident, transient ischemic attack or any revascularization within 6 months
boolean
C0002965 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0007787 (UMLS CUI [4])
C0581603 (UMLS CUI [5])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
16. uncontrolled hypertension (defined as systolic blood pressure >150 mmhg or diastolic blood pressure >95 mmhg on three or more assessments on more than one day)
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Substance Use Disorders | Alcohol consumption U/week | Beer U/week | Wine U/week | Cocktail Containing Alcohol U/week
Item
17. history of drug or alcohol abuse, or current weekly alcohol consumption >10 units/week (1 unit = 1 beer, 1 glass of wine, 1 mixed cocktail containing 1 ounce of alcohol)
boolean
C0038586 (UMLS CUI [1])
C0001948 (UMLS CUI [2,1])
C0560588 (UMLS CUI [2,2])
C0004922 (UMLS CUI [3,1])
C0560588 (UMLS CUI [3,2])
C0043188 (UMLS CUI [4,1])
C0560588 (UMLS CUI [4,2])
C0678420 (UMLS CUI [5,1])
C0332256 (UMLS CUI [5,2])
C0001962 (UMLS CUI [5,3])
C0560588 (UMLS CUI [5,4])
Hemoglobin measurement | Gender
Item
18. hemoglobin <12 g/dl (males), <10 g/dl (females) at screening
boolean
C0518015 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Platelet Count measurement
Item
19. platelets <100,000 cu mm at screening.
boolean
C0032181 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
20. ast (sgot) >2.50 x uln or alt (sgpt) >2.50 x uln at screening
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Elevated total bilirubin
Item
21. total bilirubin >1.50 x uln at screening
boolean
C0741494 (UMLS CUI [1])
Triglycerides measurement
Item
22. triglycerides (tg) >500 mg/dl at screening
boolean
C0202236 (UMLS CUI [1])
Mental function Poor | Reason for Protocol Compliance Limited
Item
23. poor mental function or any other reason to expect patient difficulty in complying with the requirements of the study
boolean
C0563143 (UMLS CUI [1,1])
C0542537 (UMLS CUI [1,2])
C0392360 (UMLS CUI [2,1])
C0525058 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Aspirin allergy
Item
24. previous allergy to aspirin
boolean
C0004058 (UMLS CUI [1])
Non-Steroidal Anti-Inflammatory Agents chronic
Item
25. chronic or continuous use (daily for more than 7 days) of nonsteroidal anti-inflammatory drugs within the preceding 2 months
boolean
C0003211 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Warfarin | Coumadin | clopidogrel | Plavix | Anticoagulants
Item
26. use of warfarin (coumadin), clopidogrel (plavix) or other anticoagulants
boolean
C0043031 (UMLS CUI [1])
C0699129 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
C0633084 (UMLS CUI [4])
C0003280 (UMLS CUI [5])
Probenecid | Benemid | Sulfinpyrazone | Anturane | Uricosuric Agents
Item
27. use of probenecid (benemid, probalan), sulfinpyrazone (anturane) or other uricosuric agents
boolean
C0033209 (UMLS CUI [1])
C0591159 (UMLS CUI [2])
C0038742 (UMLS CUI [3])
C0591099 (UMLS CUI [4])
C0041983 (UMLS CUI [5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial